abrdn plc Increases Position in The Clorox Company (NYSE:CLX)

abrdn plc increased its stake in The Clorox Company (NYSE:CLX) by 20.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 198,250 shares of the company’s stock after acquiring an additional 33,135 shares during the quarter. abrdn plc’s holdings in Clorox were worth $28,268,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Fortitude Family Office LLC purchased a new position in Clorox during the 4th quarter valued at about $29,000. Tyler Stone Wealth Management increased its holdings in Clorox by 64.5% during the 3rd quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares in the last quarter. Hartford Financial Management Inc. increased its holdings in Clorox by 57.1% during the 4th quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock valued at $37,000 after acquiring an additional 93 shares in the last quarter. Valley National Advisers Inc. increased its holdings in Clorox by 458.3% during the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock valued at $38,000 after acquiring an additional 220 shares in the last quarter. Finally, BKM Wealth Management LLC purchased a new position in Clorox during the 4th quarter valued at about $41,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 1.1 %

Shares of CLX stock opened at $145.19 on Tuesday. The stock has a market cap of $18.02 billion, a price-to-earnings ratio of 230.46, a price-to-earnings-growth ratio of 2.27 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The firm’s 50 day moving average price is $149.82 and its two-hundred day moving average price is $142.09.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. Clorox’s revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.98 earnings per share. On average, analysts anticipate that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.31%. Clorox’s dividend payout ratio (DPR) is 761.92%.

Analysts Set New Price Targets

CLX has been the subject of several recent research reports. UBS Group raised their target price on shares of Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a report on Tuesday, March 26th. Citigroup lowered their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a report on Tuesday, April 16th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Finally, Barclays lowered their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a report on Wednesday, April 10th. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $148.63.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.